| 13 weeks ended | 39 weeks ended | ||||||||||||||||||||||
| January 31, 2026 | January 25, 2025 | January 31, 2026 | January 25, 2025 | ||||||||||||||||||||
| Sales: | As Restated | As Restated | |||||||||||||||||||||
| Product sales and other | $ | 471,825 | $ | 419,663 | $ | 1,344,215 | $ | 1,230,263 | |||||||||||||||
| Rental income | 43,267 | 43,162 | 103,451 | 98,115 | |||||||||||||||||||
| Total sales | 515,092 | 462,825 | 1,447,666 | 1,328,378 | |||||||||||||||||||
| Cost of sales (exclusive of depreciation and amortization expense): | |||||||||||||||||||||||
| Product and other cost of sales | 394,782 | 343,559 | 1,109,131 | 1,005,970 | |||||||||||||||||||
| Rental cost of sales | 24,212 | 25,516 | 57,223 | 55,185 | |||||||||||||||||||
| Total cost of sales | 418,994 | 369,075 | 1,166,354 | 1,061,155 | |||||||||||||||||||
| Gross profit | 96,098 | 93,750 | 281,312 | 267,223 | |||||||||||||||||||
| Selling and administrative expenses | 72,551 | 71,561 | 217,714 | 211,524 | |||||||||||||||||||
| Depreciation and amortization expense | 7,427 | 7,827 | 24,237 | 29,440 | |||||||||||||||||||
Impairment loss (non-cash) (a) | 456 | 1,713 | 456 | 1,713 | |||||||||||||||||||
| Other expense | 1,043 | (6,268) | 6,654 | (2,800) | |||||||||||||||||||
| Operating income | 14,621 | 18,917 | 32,251 | 27,346 | |||||||||||||||||||
Loss on extinguishment of debt (a) | — | — | — | 55,233 | |||||||||||||||||||
| Interest expense, net | 4,884 | 5,083 | 12,514 | 18,164 | |||||||||||||||||||
| Income (loss) before income taxes | 9,737 | 13,834 | 19,737 | (46,051) | |||||||||||||||||||
| Income tax expense | 3,082 | (4,108) | 6,349 | (3,230) | |||||||||||||||||||
| Net income (loss) | $ | 6,655 | $ | 17,942 | $ | 13,388 | $ | (42,821) | |||||||||||||||
| Income (loss) per Common Stock: | |||||||||||||||||||||||
| Basic: | |||||||||||||||||||||||
| Total Basic Income (loss) per share | $ | 0.19 | $ | 0.59 | $ | 0.39 | $ | (1.82) | |||||||||||||||
| Weighted average common shares outstanding - Basic | 34,450,101 | 30,507,723 | 34,290,185 | 23,515,188 | |||||||||||||||||||
| Diluted: | |||||||||||||||||||||||
| Total Diluted Income (loss) per share | $ | 0.19 | $ | 0.59 | $ | 0.39 | $ | (1.82) | |||||||||||||||
| Weighted average common shares outstanding - Diluted | 34,663,763 | 30,642,958 | 34,599,168 | 23,515,188 | |||||||||||||||||||
| 13 weeks ended | 39 weeks ended | ||||||||||||||||||||||
| January 31, 2026 | January 25, 2025 | January 31, 2026 | January 25, 2025 | ||||||||||||||||||||
| As Restated | As Restated | ||||||||||||||||||||||
| Percentage of sales: | |||||||||||||||||||||||
| Sales: | |||||||||||||||||||||||
| Product sales and other | 91.6 | % | 90.7 | % | 92.9 | % | 92.6 | % | |||||||||||||||
| Rental income | 8.4 | % | 9.3 | % | 7.1 | % | 7.4 | % | |||||||||||||||
| Total sales | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||||||||||
| Cost of sales (exclusive of depreciation and amortization expense): | |||||||||||||||||||||||
Product and other cost of sales (a) | 83.7 | % | 81.9 | % | 82.5 | % | 81.8 | % | |||||||||||||||
Rental cost of sales (a) | 56.0 | % | 59.1 | % | 55.3 | % | 56.2 | % | |||||||||||||||
| Total cost of sales | 81.3 | % | 79.7 | % | 80.6 | % | 79.9 | % | |||||||||||||||
| Gross profit | 18.7 | % | 20.3 | % | 19.4 | % | 20.1 | % | |||||||||||||||
| Selling and administrative expenses | 14.1 | % | 15.5 | % | 15.0 | % | 15.9 | % | |||||||||||||||
| Depreciation and amortization expense | 1.4 | % | 1.7 | % | 1.7 | % | 2.2 | % | |||||||||||||||
| Impairment loss (non-cash) | 0.1 | % | 0.4 | % | — | % | 0.1 | % | |||||||||||||||
| Other expense | 0.2 | % | (1.4) | % | 0.5 | % | (0.2) | % | |||||||||||||||
| Operating income | 2.9 | % | 4.1 | % | 2.2 | % | 2.1 | % | |||||||||||||||
| January 31, 2026 | May 3, 2025 | ||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 10,139 | $ | 9,058 | |||||||
| Receivables, net | 416,425 | 98,077 | |||||||||
| Merchandise inventories, net | 329,425 | 299,562 | |||||||||
| Textbook rental inventories | 43,662 | 26,439 | |||||||||
| Prepaid expenses and other current assets | 26,095 | 32,249 | |||||||||
| Total current assets | 825,746 | 465,385 | |||||||||
| Property and equipment, net | 37,182 | 40,229 | |||||||||
| Operating lease right-of-use assets | 180,535 | 183,695 | |||||||||
| Intangible assets, net | 67,924 | 78,241 | |||||||||
| Other noncurrent assets | 18,921 | 22,735 | |||||||||
| Total assets | $ | 1,130,308 | $ | 790,285 | |||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 319,236 | $ | 148,848 | |||||||
| Accrued liabilities | 186,919 | 65,853 | |||||||||
| Current operating lease liabilities | 73,653 | 64,524 | |||||||||
| Total current liabilities | 579,808 | 279,225 | |||||||||
| Long-term deferred taxes, net | 85 | 1,135 | |||||||||
| Long-term operating lease liabilities | 103,959 | 115,495 | |||||||||
| Other long-term liabilities | 18,082 | 19,142 | |||||||||
| Long-term borrowings | 138,400 | 103,100 | |||||||||
| Total liabilities | 840,334 | 518,097 | |||||||||
| Commitments and contingencies | |||||||||||
| Stockholders' equity: | |||||||||||
| Preferred stock, $0.01 par value; authorized, 5,000,000 shares; issued and outstanding, none | — | — | |||||||||
| Common stock, $0.01 par value; authorized, 200,000,000 shares; issued, 34,321,836 and 34,081,114 shares, respectively; outstanding, 34,294,569 and 34,053,847 shares, respectively | 343 | 341 | |||||||||
| Additional paid-in-capital | 1,011,370 | 1,006,974 | |||||||||
| Accumulated deficit | (699,183) | (712,571) | |||||||||
| Treasury stock, at cost | (22,556) | (22,556) | |||||||||
| Total stockholders' equity | 289,974 | 272,188 | |||||||||
| Total liabilities and stockholders' equity | $ | 1,130,308 | $ | 790,285 | |||||||
| 39 weeks ended | ||||||||||||||
| January 31, 2026 | January 25, 2025 | |||||||||||||
| As Restated | ||||||||||||||
| Cash flows from operating activities: | ||||||||||||||
| Net income (loss) | $ | 13,388 | $ | (42,821) | ||||||||||
| Adjustments to reconcile net income (loss) from operations to net cash flows from operating activities: | ||||||||||||||
| Depreciation and amortization expense | 24,237 | 29,440 | ||||||||||||
| Amortization of deferred financing costs | 2,747 | 4,248 | ||||||||||||
| Impairment loss (non-cash) | 456 | 1,713 | ||||||||||||
| Loss on extinguishment of debt | — | 55,233 | ||||||||||||
| Deferred taxes | (1,050) | 2,960 | ||||||||||||
| Pension adjustments | — | — | ||||||||||||
| Stock-based compensation expense | 5,191 | 2,953 | ||||||||||||
| Changes in operating lease right-of-use assets and liabilities | 624 | (322) | ||||||||||||
| Changes in other long-term assets and liabilities, net | 1,031 | (6,006) | ||||||||||||
| Changes in other operating assets and liabilities, net: | ||||||||||||||
| Receivables, net | (318,348) | (244,681) | ||||||||||||
| Merchandise inventories, net | (29,863) | 17,212 | ||||||||||||
| Textbook rental inventories | (17,223) | (8,041) | ||||||||||||
| Prepaid expenses and other current assets | (5,273) | (5,535) | ||||||||||||
| Accounts payable and accrued liabilities | 293,331 | 55,610 | ||||||||||||
| Changes in other operating assets and liabilities | (77,376) | (185,435) | ||||||||||||
| Net cash flows used in operating activities | $ | (30,752) | $ | (138,037) | ||||||||||
| Cash flows from investing activities: | ||||||||||||||
| Purchases of property and equipment | $ | (11,781) | $ | (9,790) | ||||||||||
| Net change in other noncurrent assets | — | 792 | ||||||||||||
| Net cash flows used in investing activities | $ | (11,781) | $ | (8,998) | ||||||||||
| Cash flows from financing activities: | ||||||||||||||
| Proceeds from borrowings | $ | 604,000 | $ | 667,355 | ||||||||||
| Repayments of borrowings | (568,700) | (691,121) | ||||||||||||
| Proceeds from Private Equity Investment | — | 50,000 | ||||||||||||
| Proceeds from Rights Offering | — | 45,000 | ||||||||||||
| Proceeds from sales of Common Stock under ATM facility, net of commissions | — | 78,450 | ||||||||||||
| Payment of equity issuance costs | (795) | (9,724) | ||||||||||||
| Payment of deferred financing costs | (1,900) | (5,569) | ||||||||||||
| Purchase of treasury shares | — | (4) | ||||||||||||
| Proceeds from principal stockholder expense reimbursement | — | 1,190 | ||||||||||||
| Payment of finance lease principal | (371) | (385) | ||||||||||||
| Net cash flows provided by financing activities | $ | 32,234 | $ | 135,192 | ||||||||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | $ | (10,299) | $ | (11,843) | ||||||||||
| Cash, cash equivalents and restricted cash at beginning of period | 28,723 | 28,570 | ||||||||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 18,424 | $ | 16,727 | ||||||||||
Adjusted Net Income (Loss) (a) | 13 weeks ended | 39 weeks ended | |||||||||||||||||||||
| January 31, 2026 | January 25, 2025 | January 31, 2026 | January 25, 2025 | ||||||||||||||||||||
| As Restated | As Restated | ||||||||||||||||||||||
| Net income (loss) | $ | 6,655 | $ | 17,942 | $ | 13,388 | $ | (42,821) | |||||||||||||||
| Reconciling items (below) | 1,552 | (1,994) | 5,396 | 1,866 | |||||||||||||||||||
| Adjusted Net Income (Loss) | $ | 8,207 | $ | 15,948 | $ | 18,784 | $ | (40,955) | |||||||||||||||
| Reconciling items | |||||||||||||||||||||||
Impairment loss (non-cash) (b) | $ | 456 | $ | 1,713 | $ | 456 | $ | 1,713 | |||||||||||||||
| Other (income) expense, net of Investigation expenses | 222 | (6,268) | (251) | (2,800) | |||||||||||||||||||
| Stock-based compensation expense | 874 | 2,561 | 5,191 | 2,953 | |||||||||||||||||||
| Reconciling items | $ | 1,552 | $ | (1,994) | $ | 5,396 | $ | 1,866 | |||||||||||||||
Adjusted EBITDA (a) | 13 weeks ended | 39 weeks ended | |||||||||||||||||||||
| January 31, 2026 | January 25, 2025 | January 31, 2026 | January 25, 2025 | ||||||||||||||||||||
| As Restated | As Restated | ||||||||||||||||||||||
| Net income (loss) | $ | 6,655 | $ | 17,942 | $ | 13,388 | $ | (42,821) | |||||||||||||||
| Add: | |||||||||||||||||||||||
| Depreciation and amortization expense | 7,427 | 7,827 | 24,237 | 29,440 | |||||||||||||||||||
| Interest expense, net | 4,884 | 5,083 | 12,514 | 18,164 | |||||||||||||||||||
| Income tax expense | 3,082 | (4,108) | 6,349 | (3,230) | |||||||||||||||||||
| Impairment loss (non-cash) | 456 | 1,713 | 456 | 1,713 | |||||||||||||||||||
| Loss on extinguishment of debt | — | — | — | 55,233 | |||||||||||||||||||
| Other (income) expense, net of Investigation expenses | 222 | (6,268) | (251) | (2,800) | |||||||||||||||||||
| Stock-based compensation expense | 874 | 2,561 | 5,191 | 2,953 | |||||||||||||||||||
| Adjusted EBITDA | $ | 23,600 | $ | 24,750 | $ | 61,884 | $ | 58,652 | |||||||||||||||
| 13 weeks ended | 39 weeks ended | ||||||||||||||||||||||
| Dollars in thousands | January 31, 2026 | January 25, 2025 | January 31, 2026 | January 25, 2025 | |||||||||||||||||||
| As Restated | As Restated | ||||||||||||||||||||||
| Net cash flows (used in) provided by operating activities | $ | (29,388) | $ | (41,945) | $ | (30,752) | $ | (138,037) | |||||||||||||||
| Less: | |||||||||||||||||||||||
Capital expenditures (b) | 3,807 | 2,772 | 11,858 | 9,790 | |||||||||||||||||||
| Cash interest | 3,656 | 4,633 | 9,961 | 14,499 | |||||||||||||||||||
| Cash taxes | 1,412 | 67 | 1,724 | (2,018) | |||||||||||||||||||
| Free Cash Flow (non-GAAP) | $ | (38,263) | $ | (49,417) | $ | (54,295) | $ | (160,308) | |||||||||||||||
| Capital Expenditures | 13 weeks ended | 39 weeks ended | |||||||||||||||||||||
| Dollars in thousands | January 31, 2026 | January 25, 2025 | January 31, 2026 | January 25, 2025 | |||||||||||||||||||
| As Restated | As Restated | ||||||||||||||||||||||
| Physical store capital expenditures | $ | 1,975 | $ | 1,219 | $ | 7,325 | $ | 5,059 | |||||||||||||||
| Product and system development | 1,425 | 1,378 | 3,700 | 4,086 | |||||||||||||||||||
| Other | 407 | 175 | 833 | 645 | |||||||||||||||||||
| Total Capital Expenditures | $ | 3,807 | $ | 2,772 | $ | 11,858 | $ | 9,790 | |||||||||||||||